We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

118 hedge funds and large institutions have $264M invested in Albany Molecular Research Inc in 2013 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 28 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 9

82% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 28

15% more funds holding

Funds holding: 103 → 118 (+15)

13% more call options, than puts

Call options by funds: $1.43M | Put options by funds: $1.26M

2% less capital invested

Capital invested by funds: $269M → $264M (-$4.3M)

Holders
118
Holders Change
+15
Holders Change %
+14.56%
% of All Funds
3.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
51
Reduced
28
Closed
9
Calls
$1.43M
Puts
$1.26M
Net Calls
+$169K
Net Calls Change
+$101K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$28.4M
2
VAM
Visium Asset Management
New York
+$13.5M
3
BIT
BlackRock Institutional Trust
California
+$6.67M
4
RA
Royce & Associates
New York
+$5.05M
5
JP Morgan Chase
JP Morgan Chase
New York
+$3.81M

Top Sellers

Rank Fund Capital Flow
1
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$4.57M
2
TC
TFS Capital
Pennsylvania
-$3.62M
3
BIM
Bogle Investment Management
Massachusetts
-$3.6M
4
EI
EAM Investors
California
-$2.48M
5
Invesco
Invesco
Georgia
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
76
Metropolitan Life Insurance Company (MetLife)
New York
$199K – – –
Los Angeles Capital Management
77
Los Angeles Capital Management
California
$193K +$232K +19,190 New
VOYA Investment Management
78
VOYA Investment Management
Georgia
$187K – – –
DekaBank Deutsche Girozentrale
79
DekaBank Deutsche Girozentrale
Germany
$182K +$6.04K +500 +3%
CCMH
80
Cornerstone Capital Management Holdings
New York
$172K +$22.6K +1,871 +12%
Citigroup
81
Citigroup
New York
$164K +$46.8K +3,869 +31%
First Trust Advisors
82
First Trust Advisors
Illinois
$161K -$120K -9,949 -38%
ProShare Advisors
83
ProShare Advisors
Maryland
$158K -$123K -10,209 -39%
AIG
84
American International Group
New York
$156K -$1.87K -155 -1%
BA
85
BlackRock Advisors
Delaware
$152K +$2.63K +218 +1%
Bank of America
86
Bank of America
North Carolina
$152K +$149K +12,352 +456%
OTPPB
87
Ontario Teachers' Pension Plan Board
Ontario, Canada
$149K -$95.1K -7,873 -35%
GMIM
88
General Motors Investment Management
New York
$147K +$176K +14,537 New
TC
89
TFS Capital
Pennsylvania
$140K -$3.62M -299,618 -96%
SCM
90
Stevens Capital Management
Pennsylvania
$135K +$162K +13,404 New
Bank of Nova Scotia
91
Bank of Nova Scotia
Ontario, Canada
$131K +$157K +13,000 New
QI
92
QS Investors
New York
$127K +$152K +12,600 New
ARTA
93
A.R.T. Advisors
New York
$126K +$21.2K +1,753 +16%
Jane Street
94
Jane Street
New York
$124K +$149K +12,334 New
VKH
95
Virtu KCG Holdings
New York
$121K +$145K +12,022 New
US Bancorp
96
US Bancorp
Minnesota
$117K -$3.08K -255 -2%
Bank of Montreal
97
Bank of Montreal
Ontario, Canada
$116K +$17.8K +1,469 +15%
WMSA
98
Weiss Multi-Strategy Advisers
New York
$116K +$140K +11,550 New
Susquehanna International Group
99
Susquehanna International Group
Pennsylvania
$113K +$135K +11,185 New
QI
100
Quotient Investors
New York
$109K +$131K +10,800 New
2 3
4
5 6

AMRI Hedge Fund Activity: Q4 2013 in Review

118 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q4 2013, worth a combined $264M — down 1.6% from $269M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new AMRI positions and 9 closed out — a net gain of 15 holders — while 51 added to existing stakes and 28 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $28.4M. The largest seller was Fuller & Thaler Asset Management, exiting entirely with an estimated $4.57M sold.

  • 118 institutional investors held Albany Molecular Research Inc (AMRI) as of Q4 2013, up from 103 in Q3 2013.
  • Funds reported $264M of Albany Molecular Research Inc stock for Q4 2013, down 1.6% quarter-over-quarter.
  • 24 funds opened new Albany Molecular Research Inc positions in Q4 2013 and 9 closed out, a net change of +15 holders.
  • The largest Albany Molecular Research Inc buyer in Q4 2013 was Wellington Management Group, an estimated $28.4M added.
  • The largest Albany Molecular Research Inc seller in Q4 2013 was Fuller & Thaler Asset Management, an estimated $4.57M sold.

Based on aggregated 13F filings for Q4 2013.